Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Colonic Neoplasms 70Rectal Neoplasms 67Colorectal Neoplasms 61Breast Neoplasms 26Pancreatic Neoplasms 15Head and Neck Neoplasms 13Neoplasm Metastasis 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Unspecified Adult Solid Tumor, Protocol Specific 9Stomach Neoplasms 8Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Kidney Neoplasms 4Gallbladder Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Oropharyngeal Neoplasms 3Neoplasms 3Nasopharyngeal Neoplasms 3Lymphoma 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Anus Neoplasms 3Uterine Cervical Dysplasia 2Salivary Gland Neoplasms 2

Interventions

Cetuximab 7Magnetic Resonance Spectroscopy 5Radiotherapy 4Erlotinib Hydrochloride 4Cisplatin 4Bevacizumab 4Trastuzumab 3Specimen Handling 3Radiotherapy, Conformal 3Carboplatin 3sargramostim 2ixabepilone 2Vorinostat 2Sorafenib 2SS1(dsFv)PE38 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lapatinib 2Fluorouracil 2Fluorodeoxyglucose F18 2Docetaxel 2Dasatinib 2Chemotherapy, Adjuvant 2Biopsy 2trastuzumab deruxtecan 1tipifarnib 1temsirolimus 1temoporfin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Salivary Gland Neoplasms × Fluorouracil × Clear all
NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00023959 2013-02-07

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡